Filter your results
- 4
- 4
- 3
- 2
- 2
- 4
- 3
- 3
- 1
- 1
- 1
- 4
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
The mutational spectrum of HRAS, KRAS, NRAS and FGFR3 genes in bladder cancer.Cancer Biomarkers, 2013, 10 (6), pp.259-66. ⟨10.3233/CBM-2012-0254⟩
Journal articles
pasteur-00879650v1
|
|||
The prevalence and prognostic significance of KRAS mutation in bladder cancer, chronic myeloid leukemia and colorectal cancer.Molecular Biology Reports, 2013, 40 (6), pp.4109-14. ⟨10.1007/s11033-013-2512-8⟩
Journal articles
istex
pasteur-00861358v1
|
|||
Smoking and Polymorphisms in Xenobiotic Metabolism and DNA Repair Genes are Additive Risk Factors Affecting Bladder Cancer in Northern TunisiaPathology and Oncology Research, 2011, 17 (4), pp.879-886. ⟨10.1007/s12253-011-9398-3⟩
Journal articles
pasteur-01375279v1
|
|||
Influence of genetic polymorphisms of xenobiotic metabolizing enzymes on the risk of developing leukemia in a Tunisian population.Bulletin du Cancer, 2011, 98 (12), pp.95-106. ⟨10.1684/bdc.2011.1502⟩
Journal articles
pasteur-01375154v1
|